Morning Bid: Trade deals bring happy days again
You get a trade deal! You get a trade deal! Everybody gets a trade deal!
Well, it's not quite like Oprah doling out new cars, but trade agreements to avert the punishing tariffs from U.S. President Donald Trump are popping up all over the place, and markets are welcoming each with relief and enthusiasm.
Stock indexes in Tokyo and Singapore followed in the footsteps of Wall Street to chart new all-time highs. The Trump administration reached trade pacts with Japan, the Philippines and Indonesia, and the European Union and South Korea could be next in line.
The EU and U.S. are closing in on a deal that would impose 15% tariffs on European imports, while waiving duties on some items, according to officials from the European Commission. Meanwhile, Treasury Secretary Scott Bessent said U.S. and Chinese officials will meet in Stockholm next week.
Earnings season is under way in the U.S., with 23% of the companies in the S&P 500 having reported. Of those, 85% have beaten Wall Street expectations, according to LSEG data.
Results from Magnificent Seven members - a group of high-performing tech stocks that powered Wall Street's rally for years - are in the spotlight for guidance on spending and returns surrounding artificial intelligence (AI).
Nasdaq and S&P futures rose after Google parent Alphabet posted a beat on earnings after the bell and outlined an expanded capital spending plan. Equity futures are pointing to strong openings across Europe.
But it's not all sunshine and lollipops. Luxury goods giant LVMH is expected to report another drop in quarterly sales, deepening investor worries about a prolonged downturn in the $400 billion market in the face of U.S. tariffs.
The results will likely show that any revival in demand for pricey fashion in the key U.S. and Chinese markets remains elusive. French luxury group Kering will report next week.
And the White House said overnight that Trump will go to the Federal Reserve on Thursday, a visit that follows his threats to fire Fed Chair Jerome Powell that have rattled U.S. bonds markets.
Key developments that could influence markets on Thursday:
- European earnings: LVMH, Deutsche Bank, BNP Paribas, Roche Holding, Nestle, Lloyds Banking Group
- U.S. earnings: Blackstone, Honeywell International, American Airlines
- European Central Bank monetary policy meeting, followed by comments from President Christine Lagarde
- July flash PMIs for the euro zone, Britain and the U.S.
- European data: Germany GfK consumer sentiment for August, UK GfK consumer confidence for July
- U.S. data: initial jobless claims, new home sales
- Canada retail sales
Trying to keep up with the latest tariff news?
Our new daily news digest offers a rundown of the top market-moving headlines impacting global trade. Sign up for Tariff Watch here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Spirax Group (LON:SPX) Has Announced A Dividend Of £0.489
Spirax Group plc's (LON:SPX) investors are due to receive a payment of £0.489 per share on 14th of November. This makes the dividend yield about the same as the industry average at 2.3%. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. Spirax Group's Projected Earnings Seem Likely To Cover Future Distributions While it is always good to see a solid dividend yield, we should also consider whether the payment is feasible. Prior to this announcement, Spirax Group's dividend made up quite a large proportion of earnings but only 52% of free cash flows. In general, cash flows are more important than earnings, so we are comfortable that the dividend will be sustainable going forward, especially with so much cash left over for reinvestment. Looking forward, earnings per share is forecast to rise by 51.7% over the next year. Assuming the dividend continues along the course it has been charting recently, our estimates show the payout ratio being 54% which brings it into quite a comfortable range. View our latest analysis for Spirax Group Spirax Group Has A Solid Track Record Even over a long history of paying dividends, the company's distributions have been remarkably stable. The dividend has gone from an annual total of £0.669 in 2015 to the most recent total annual payment of £1.65. This implies that the company grew its distributions at a yearly rate of about 9.4% over that duration. The dividend has been growing very nicely for a number of years, and has given its shareholders some nice income in their portfolios. Dividend Growth May Be Hard To Achieve Some investors will be chomping at the bit to buy some of the company's stock based on its dividend history. Unfortunately things aren't as good as they seem. Unfortunately, Spirax Group's earnings per share has been essentially flat over the past five years, which means the dividend may not be increased each year. Our Thoughts On Spirax Group's Dividend Overall, we always like to see the dividend being raised, but we don't think Spirax Group will make a great income stock. The company is generating plenty of cash, but we still think the dividend is a bit high for comfort. Overall, we don't think this company has the makings of a good income stock. Companies possessing a stable dividend policy will likely enjoy greater investor interest than those suffering from a more inconsistent approach. At the same time, there are other factors our readers should be conscious of before pouring capital into a stock. For example, we've picked out 1 warning sign for Spirax Group that investors should know about before committing capital to this stock. Looking for more high-yielding dividend ideas? Try our collection of strong dividend payers. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
17 minutes ago
- Yahoo
Be Sure To Check Out Supreme Plc (LON:SUP) Before It Goes Ex-Dividend
Readers hoping to buy Supreme Plc (LON:SUP) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date generally occurs two days before the record date, which is the day on which shareholders need to be on the company's books in order to receive a dividend. The ex-dividend date is important as the process of settlement involves at least two full business days. So if you miss that date, you would not show up on the company's books on the record date. Therefore, if you purchase Supreme's shares on or after the 21st of August, you won't be eligible to receive the dividend, when it is paid on the 23rd of September. The company's next dividend payment will be UK£0.034 per share, and in the last 12 months, the company paid a total of UK£0.052 per share. Calculating the last year's worth of payments shows that Supreme has a trailing yield of 2.8% on the current share price of UK£1.86. If you buy this business for its dividend, you should have an idea of whether Supreme's dividend is reliable and sustainable. So we need to investigate whether Supreme can afford its dividend, and if the dividend could grow. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Dividends are typically paid from company earnings. If a company pays more in dividends than it earned in profit, then the dividend could be unsustainable. Supreme paid out a comfortable 26% of its profit last year. That said, even highly profitable companies sometimes might not generate enough cash to pay the dividend, which is why we should always check if the dividend is covered by cash flow. Thankfully its dividend payments took up just 27% of the free cash flow it generated, which is a comfortable payout ratio. It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously. See our latest analysis for Supreme Click here to see the company's payout ratio, plus analyst estimates of its future dividends. Have Earnings And Dividends Been Growing? Businesses with strong growth prospects usually make the best dividend payers, because it's easier to grow dividends when earnings per share are improving. If earnings decline and the company is forced to cut its dividend, investors could watch the value of their investment go up in smoke. Fortunately for readers, Supreme's earnings per share have been growing at 15% a year for the past five years. Earnings per share are growing rapidly and the company is keeping more than half of its earnings within the business; an attractive combination which could suggest the company is focused on reinvesting to grow earnings further. Fast-growing businesses that are reinvesting heavily are enticing from a dividend perspective, especially since they can often increase the payout ratio later. Many investors will assess a company's dividend performance by evaluating how much the dividend payments have changed over time. Supreme has delivered 24% dividend growth per year on average over the past four years. It's great to see earnings per share growing rapidly over several years, and dividends per share growing right along with it. To Sum It Up Should investors buy Supreme for the upcoming dividend? Supreme has grown its earnings per share while simultaneously reinvesting in the business. Unfortunately it's cut the dividend at least once in the past four years, but the conservative payout ratio makes the current dividend look sustainable. There's a lot to like about Supreme, and we would prioritise taking a closer look at it. So while Supreme looks good from a dividend perspective, it's always worthwhile being up to date with the risks involved in this stock. We've identified 2 warning signs with Supreme (at least 1 which shouldn't be ignored), and understanding these should be part of your investment process. If you're in the market for strong dividend payers, we recommend checking our selection of top dividend stocks. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Boston Globe
an hour ago
- Boston Globe
Who really suffers from Trump Derangement Syndrome?
Get The Gavel A weekly SCOTUS explainer newsletter by columnist Kimberly Atkins Stohr. Enter Email Sign Up Two decades on, Krauthammer's coinage has been appropriated, rebranded, and defined down — way down. 'Trump Derangement Syndrome' is now flung at anyone who objects to President Trump's conduct or opposes his policies. The term is no longer reserved for over-the-top expressions of revulsion — like actor Robert De Niro using a televised appearance at the Tony Awards to Advertisement No — today 'Trump Derangement Syndrome' is used as an all-purpose put-down to deride any Trump critics, including those who stick to serious, fact-based analysis. I've lost count of all the times I've been Advertisement A woman seen at the Iowa State Fairgrounds on July 3, when President Trump was speaking there. Scott Olson/Getty The word 'syndrome' notwithstanding, this is merely political trash talk, popularized by Trump and his allies as a way to wave off criticism without having to engage it. Instead of refuting arguments or defending policy, the magic letters 'TDS' turn disagreement into proof of mental defect. Yet if 'derangement' means the loss of proportion and judgment Krauthammer was getting at, then the most severe cases aren't among Trump's critics. They're in the ranks of his most ardent loyalists. The real Trump Derangement Syndrome shows up in three telltale symptoms. First is the cult-like worship that treats Trump as infallible — his acolytes profess adoration not only for what he does, but for whatever could flow from him. Emblematic of that mindset are the Advertisement Second is the abandonment of principles that once seemed non-negotiable. Conservatives and Republicans who used to champion free trade A man with a MAGA tattoo on his stomach attended a rally at Macomb Community College in Warren, Mich., to mark President Trump's 100th day in office on April 29. EMILY ELCONIN/NYT Third is the unsettling delight so many supporters take in Trump's most outrageous behavior — a kind of giddy worship that equates offensiveness with authenticity. Such brazenness has been a hallmark of his political career — from mocking John McCain's Vietnam War heroism to charging undocumented immigrants with ' Advertisement Meanwhile, they reflexively use 'TDS!' as a go-to put-down for anything from mild disagreement to serious moral critique, framing opposition not as argument but as pathology — an easy, cheap discredit. Yes, plenty of Trump-haters go overboard — but in MAGA circles, the 'TDS' tag is sprayed far wider, hitting thoughtful critics just as readily as the genuinely unhinged. What is truly alarming is how some have sought to legalize that insult by casting dissent as disease. In Minnesota this spring, five Republican senators proposed a bill that would Krauthammer's original point in 2003 was that derangement is the breakdown of proportion and prudence. That breakdown isn't found among critics who quote Trump accurately and challenge his claims. The most alarming political derangement today affects those who cannot conceive that there are legitimate reasons to be appalled by the president, and so explain anti-Trump dissent as a sign of mental weakness. If reason is the measure, then those who shout 'TDS!' the loudest are the ones most in need of treatment. Jeff Jacoby can be reached at
